Janus Henderson Group plc 13D and 13G filings for BioCryst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 12:54 pm Sale |
2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-9,408,481 (Position Closed) |
Filing |